These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10768608)

  • 21. [Guillain-Barré syndrome].
    Koga M; Yuki N
    Ryoikibetsu Shokogun Shirizu; 2000; (31):35-8. PubMed ID: 11269101
    [No Abstract]   [Full Text] [Related]  

  • 22. Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection.
    Simpson BS; Rajabally YA
    Eur J Neurol; 2009 Apr; 16(4):e81. PubMed ID: 19222546
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
    Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
    Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
    Yuki N; Susuki K; Hirata K
    Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-GQ1b IgG antibody syndrome: clinical and immunological range.
    Panda S; Tripathi M
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):418-9. PubMed ID: 11861717
    [No Abstract]   [Full Text] [Related]  

  • 29. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
    Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies.
    Doppler K; Stengel H; Appeltshauser L; Grosskreutz J; Man Ng JK; Meinl E; Sommer C
    J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1145-1151. PubMed ID: 29945879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guillain-Barré syndrome variant with facial diplegia and paresthesias associated with IgM anti-GalNAc-GD1a antibodies.
    Hayashi R; Yamaguchi S
    Intern Med; 2015; 54(3):345-7. PubMed ID: 25748745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry.
    Kusunoki S; Shiina M; Kanazawa I
    Neurology; 2001 Aug; 57(4):736-8. PubMed ID: 11524496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.
    Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N
    J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case with upper limb dominant Guillain-Barré syndrome and serum IgG anti-GT1a antibodies: sparing oropharyngeal palsy].
    Ogawa K; Hoshino H; Takagi M; Mizoi Y; Irie S; Saito T
    Rinsho Shinkeigaku; 2001 Oct; 41(10):679-82. PubMed ID: 11993188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Axonal Guillain-Barré syndrome and physiological role of gangliosides in saltatory conduction of myelinated nerve fibers].
    Susuki K; Yuki N
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(15 Suppl):2479-84. PubMed ID: 15553005
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presynaptic neuromuscular transmission block in Guillain-Barré syndrome associated with anti-GQ1b antibodies.
    Wirguin I; Ifergane G; Almog Y; Lieberman D; Bersudsky M; Herishanu YO
    Neuromuscul Disord; 2002 Mar; 12(3):292-3. PubMed ID: 11801402
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurological syndromes associated with nervous system-specific autoantibodies.
    Abuaf N
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):1-5. PubMed ID: 11064821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.